SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is drawing significant attention from its passionate community, who are actively discussing its organic growth, fully circulated supply, and unique multi-chain presence across Solana, BSC, CRO, and Ethereum, along with a deflationary burn mechanism.

WorldFinancial

WorldFinancial (WLFI) is trending due to a congressional probe into a $500 million investment deal with a UAE entity, sparking polarized community debate as skeptics label it a scam while supporters rally behind its Trump family ties and potential for stablecoin utility and real-world asset tokenization.

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical, Risk, Legal Exhibitions and Print & print-related. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity. The Risk segment provides customers with solutions and decision tools that combine public and industry specific content with advanced technology and analytics to assist them in evaluating and predicting risk and enhancing operational efficiency. The Legal segment is a global provider of legal, regulatory and business information and analytics that helps customers increase productivity, improve decision-making and outcomes and advance the rule of law around the world. The Exhibitions segment is an event business, enhancing the effect of face-to-face through data and digital tools. The Print & print-related segment consistent with financial information provided to the board. The company was founded by Albert Edward Reed in 1903 and is headquartered in London, the United Kingdom.

RELX Plc - ADR

RELX is trending amidst a notable sell-off driven by fears that new AI tools, like Anthropic's Claude legal plugin, could disrupt its core legal and information services business. Despite these concerns, many in the community view the decline as an overreaction, emphasizing RELX's strong data moats, high-quality subscription model, and internal AI integration as key factors for a potential rebound and long-term resilience.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

ALMU is trending as its patented technology for integrating high-performance compound semiconductors on large silicon wafers is gaining significant attention as a game-changer for energy-efficient AI optical interconnects, advanced mobile sensors, and quantum computing. Community chatter focuses on the company's low-float and near-term commercialization pivot, with investors eagerly anticipating strategic partnerships and design wins.

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

Pulse Biosciences Inc

Pulse Biosciences is a focal point of investor debate after receiving FDA Breakthrough Device Designation for its cardiac surgery system while simultaneously facing a 510(k) rejection for its cardiac clamp, which pushes back market availability and necessitates a dilutive equity offering. The community is actively weighing the long-term potential of its innovative nsPFA platform technology against immediate regulatory hurdles and capital-raising efforts.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

GHOST CRYPTO is a trending Solana privacy utility token, capturing community attention for its resilience in a down market and recent integration with Solflare. Enthusiasm is high for its upcoming Ghostswap launch and a revenue-sharing model, with many anticipating substantial growth as a key player in the privacy narrative.

Lighter is a decentralized trading platform built for unmatched security and scale. It’s the first exchange to offer verifiable order matching and liquidations while delivering best-in-class performance on par with traditional exchanges.

lighter

LIT Crypto (Lighter) is trending as it transforms into a full Layer 2 EVM blockchain, with community discussion highlighting mandatory staking requirements and protocol buybacks creating a significant supply shock. This, coupled with institutional backing, positions it as a strong performer despite broader market weakness.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and decor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is trending after its Q3 earnings miss, cautious 2026 outlook citing weak housing demand, and news of corporate job cuts and a full return-to-office, fueling concerns about a "renovation recession." Community discussions are split between bearish sentiment over macroeconomic headwinds and bullish views on its long-term Pro strategy and digital investments creating a "buy the dip" opportunity.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco Systems is trending as it achieves new all-time highs for the first time in over two decades, fueled by robust demand for its AI infrastructure and a successful pivot towards software and security solutions. The community is noting this historic comeback, viewing it as a foundational player in the expanding AI ecosystem.

Under Armour, Inc. engages in the development, marketing, and distribution of branded performance apparel, footwear, and accessories for men, women, and youth. It operates through the following geographical segments: North America, EMEA, Asia-Pacific, Latin America, and Other. The company was founded by Kevin A. Plank in 1996 and is headquartered in Baltimore, MD.

Under Armour Inc - Ordinary Shares - Class C

Under Armour Inc Class C

Under Armour is trending as Fairfax Financial, led by renowned investor Prem Watsa, has significantly increased its stake, signaling strong insider confidence and fueling community discussions of a potential short squeeze given the stock's high short interest and perceived undervaluation amidst its turnaround efforts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BIOA BioAge Labs price target raised to $23 from $12 at Morgan Stanley

Reputed analysts started noticing $BIOA 

Last week PR
Piper Sandler initiated coverage of BioAge Labs () with an Overweight rating and $73  PT

They are a BioTech company with partnerships with $LLY $NVO

$BIOA is doing that “quietly coiling under supply” thing again. It has that “compression + calendar” setup traders actually care about.

TA: price keeps compressing into overhead supply — I’m watching ~$20–21 as the pivot. Break/hold there on real volume is the trigger.

Filings (not vibes):
• Company just priced an offering: 5.897M shares at $19.50, with a 30-day option for +0.885M shares.  
• Net proceeds estimated ~$107.6M, earmarked to fund BGE-102 + pipeline work.  
• And they laid out a straight catalyst runway: full Phase 1 readout in 1H’26, Phase 2a start in 1H’26, DME POC start mid-’26, 2H’26 data, mid-’27 DME readout.  

Dilution is real — but so is the “funded + milestone ladder” effect. Watching for the tape to confirm.

StockTwits for iOS

BioAge Labs Inc.

JustAnotherGuy

Lilly(Eli) & Co

Novo Nordisk A/S

 BioAge Labs price target raised to $23 from $12 at Morgan Stanley

Reputed analysts started noticing 

 

Last week PR
Piper Sandler initiated coverage of BioAge Labs () with an Overweight rating and $73  PT

They are a BioTech company with partnerships with 